Clinical Trials Browser

Phase 2/3 × OTHER × Carcinoma, Renal Cell × Clear all

NCT02883153 2017-06-19

Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma

Phase 2/3 Completed

Carcinoma, Renal Cell

NCT02030717 2015-06-04

ASA

Phase 2/3 Completed

Carcinoma, Renal Cell